EOI Block in Otoplasty With Rib Cartilage Graft
ConditionPostoperative Pain, Acute
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age13-18
SponsorSeoul National University Hospital
About this trial
This randomized controlled trial aims to evaluate the effect of ultrasound-guided external oblique intercostal (EOI) fascial plane block on postoperative pain control and recovery in pediatric patients undergoing otoplasty with rib cartilage graft under general anesthesia. Participants aged 13 to 18 years will be randomly assigned to receive either EOI block with 0.2% ropivacaine or no block. Primary outcome is total opioid consumption within 24 hours after surgery. Secondary outcomes include NRS pain scores, incentive spirometry performance, incidence of atelectasis, and patient satisfaction.
Eligibility criteria
Qualifiers
- Pediatric patients aged 13 to 18 years undergoing otoplasty with rib cartilage graft under general anesthesia at Seoul National University Children's Hospital
Written informed consent obtained from parent or legal guardian, and assent from the patient
Disqualifiers
Unstable vital signs before surgery (heart rate <50 or >150 beats/min, systolic blood pressure <80 mmHg or >160 mmHg)
Known hypersensitivity to ropivacaine or other amide-type local anesthetics
Massive bleeding or shock
Local infection at the injection site
Trial design
Treatments tested in this trial
- Ultrasound-guided External Oblique Intercostal (EOI) Fascial Plane Block
- Standard postoperative pain management (no EOI block)
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov